[Progress in molecular genetics of epilepsy with myoclonic-atonic seizure].
Rapid seizure resolution with cannabidiol in medically refractory epilepsy with myoclonic-atonic seizures.
Epilepsy with myoclonic-atonic seizures, also known as Doose syndrome: Modification of the diagnostic criteria.
Oguni H.
Eur J Paediatr Neurol. 2022 Jan;36:37-50. doi: 10.1016/j.ejpn.2021.11.009. Epub 2021 Dec 1.
Epilepsy with myoclonic-atonic seizures (Doose syndrome): Clarification of diagnosis and treatment options through a large retrospective multicenter cohort.
Nickels K, Kossoff EH, Eschbach K, Joshi C.
Epilepsia. 2021 Jan;62(1):120-127. doi: 10.1111/epi.16752. Epub 2020 Nov 14.
Phenotypic and genetic spectrum of epilepsy with myoclonic atonic seizures.
Tang S, Addis L, Smith A, Topp SD, Pendziwiat M, Mei D, Parker A, Agrawal S, Hughes E, Lascelles K, Williams RE, Fallon P, Robinson R, Cross HJ, Hedderly T, Eltze C, Kerr T, Desurkar A, Hussain N, Kinali M, Bagnasco I, Vassallo G, Whitehouse W, Goyal S, Absoud M; EuroEPINOMICS-RES Consortium; Møller RS, Helbig I, Weber YG, Marini C, Guerrini R, Simpson MA, Pal DK.
Epilepsia. 2020 May;61(5):995-1007. doi: 10.1111/epi.16508. Epub 2020 May 29.
Epilepsy with myoclonic-atonic seizures: an update on genetic causes, nosological limits, and treatment strategies.
Guerrini R, Scheffer I, Balestrini S.
Lancet Neurol. 2025 Apr;24(4):348-360. doi: 10.1016/S1474-4422(25)00032-8.
Recent advances in pharmacotherapy for epilepsy.
Pong AW, Xu KJ, Klein P.
Curr Opin Neurol. 2023 Apr 1;36(2):77-85. doi: 10.1097/WCO.0000000000001144. Epub 2023 Feb 10.
International consensus on diagnosis and management of Dravet syndrome.
Wirrell EC, Hood V, Knupp KG, Meskis MA, Nabbout R, Scheffer IE, Wilmshurst J, Sullivan J.
Epilepsia. 2022 Jul;63(7):1761-1777. doi: 10.1111/epi.17274. Epub 2022 May 12.
Genetic therapeutic advancements for Dravet Syndrome.
Chilcott E, Díaz JA, Bertram C, Berti M, Karda R.
Epilepsy Behav. 2022 Jul;132:108741. doi: 10.1016/j.yebeh.2022.108741. Epub 2022 May 30.
Cannabidiol in children with treatment-resistant epilepsy with myoclonic-atonic seizures.
Caraballo RH, Reyes Valenzuela G, Fortini S, Espeche A, Gamboni B, Silva W, Semprino M, Fasulo L, Chacón S, Gallo A, Galicchio S, Cachia P.
Epilepsy Behav. 2023 Jun;143:109245. doi: 10.1016/j.yebeh.2023.109245. Epub 2023 May 12.
Advances in the Treatment of Drug-Resistant Pediatric Epilepsy.
Gonzalez-Giraldo E, Sullivan JE.
Semin Neurol. 2020 Apr;40(2):257-262. doi: 10.1055/s-0040-1702941. Epub 2020 Mar 17.
Epilepsy with myoclonic absences.
Genton P, Bureau M.
CNS Drugs. 2006;20(11):911-6. doi: 10.2165/00023210-200620110-00004.
